Acta Clinica Belgica最新文献

筛选
英文 中文
Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck: a case series of five patients. 索拉非尼治疗头颈部腺样囊性癌的疗效和毒性:5例患者的病例系列。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2020-10-01 Epub Date: 2019-06-23 DOI: 10.1080/17843286.2019.1633490
Karen Couvreur, Jacobs Celine, Bock Marlies, D'Hondt Randal, Deron Philippe, Duprez Frederic, Rottey Sylvie
{"title":"Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck: a case series of five patients.","authors":"Karen Couvreur,&nbsp;Jacobs Celine,&nbsp;Bock Marlies,&nbsp;D'Hondt Randal,&nbsp;Deron Philippe,&nbsp;Duprez Frederic,&nbsp;Rottey Sylvie","doi":"10.1080/17843286.2019.1633490","DOIUrl":"https://doi.org/10.1080/17843286.2019.1633490","url":null,"abstract":"<p><strong>Introduction: </strong>Adenoid cystic carcinoma (ACC) of the head and neck is a rare malignancy of the salivary glands that accounts for approximately 10% of salivary gland carcinoma. Despite aggressive local therapy, local recurrence and distant metastases occur frequently. Response rates (RR) to potential curative and palliative chemotherapy are limited, so new strategies are needed.</p><p><strong>Case reports: </strong>We describe five case reports of patients with unresectable locally advanced or metastatic ACC of the head and neck who have been treated with sorafenib, a multi-tyrosine kinase inhibitor (mTKI).</p><p><strong>Results: </strong>In this case series, we found that three out of five patients treated with sorafenib survived, respectively, 16, 35 and 35 months. Two patients showed a partial response (PR) and one patient had a prolonged stable disease (SD) for almost three years. Grade 3 adverse events (AE) occur under sorafenib so adequate toxicity management is essential. This retrospective case series hints towards the possibility of clinical benefit for treating ACC patients with sorafenib. Efficacy of sorafenib should be studied in a prospective-randomized clinical trial which is a challenging task due to the rarity of the disease.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"75 5","pages":"362-369"},"PeriodicalIF":1.6,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17843286.2019.1633490","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37355745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Orthostatic blood pressure drop and cardiovascular and psychotropic medication dosages in acutely ill geriatric inpatients. 老年急性病住院患者体位血压下降与心血管和精神药物剂量的关系。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2020-10-01 Epub Date: 2019-05-29 DOI: 10.1080/17843286.2019.1623516
J Paul, F Vaillant, O Vanden Bossche, T Pepersack, S Henrard, B Boland
{"title":"Orthostatic blood pressure drop and cardiovascular and psychotropic medication dosages in acutely ill geriatric inpatients.","authors":"J Paul,&nbsp;F Vaillant,&nbsp;O Vanden Bossche,&nbsp;T Pepersack,&nbsp;S Henrard,&nbsp;B Boland","doi":"10.1080/17843286.2019.1623516","DOIUrl":"https://doi.org/10.1080/17843286.2019.1623516","url":null,"abstract":"<p><strong>Objectives: </strong>. To investigate the dose-response relationship between cardiovascular or psychotropic medication dosages and falling orthostatic blood pressure in geriatric inpatients.</p><p><strong>Methods: </strong>. This cross-sectional study included 100 consecutive geriatric inpatients of a Belgian hospital. The end points were the maximum changes of systolic (sBP) and diastolic (dBP) blood pressure in a standing up position at one or three minutes. The dosages of six classes of vascular and five classes of psychotropic medications were expressed in terms of a proportion of defined daily doses (DDD). Bivariate and multivariate linear regression models were used.</p><p><strong>Results: </strong>. The 100 geriatric patients (85 ± 5 years, 58 % women) received 7.7 ± 4 medications (mean DDD: vascular = 1.0, psychotropic = 0.74) on the day of an orthostatic test (lying sBP: 136 ± 21; dBP: 72 ± 14 mm Hg). In a standing position, sBP and dBP fell by 12 ± 17 and 11 ± 5 mmHg, respectively. At the individual level, BP change was not correlated with vascular DDD (sBP: p = 0.07, r<sup>2</sup> = 0.04; dBP: p = 0.59; r<sup>2</sup> = 0.004) nor with psychotropic DDD (sBP: p = 0.14, r<sup>2</sup> = 0.02; dBP: p = 0.82; r<sup>2</sup> = 0.0). In multivariate analysis, sBP drop was positively associated with age, diabetes, falls history, and number of medications, but not with the DDD of any of the medication classes, while dBP drop was positively associated with age, diabetes, stroke and anaemia, but again with the DDD of any of the medication classes.</p><p><strong>Conclusion: </strong>. No correlation was found between vascular and psychotropic medication dosages and the orthostatic blood pressure drop expressed as a continuous variable.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"75 5","pages":"313-320"},"PeriodicalIF":1.6,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17843286.2019.1623516","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37288674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Dissatisfaction and Burnout among Flemish emergency physicians: a qualitative study. 佛兰德急诊科医师的不满与倦怠:一项质性研究。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2020-10-01 Epub Date: 2019-06-11 DOI: 10.1080/17843286.2019.1629077
Ine Van Bogaert, Catheline Depuydt, Said Hachimi-Idrissi
{"title":"Dissatisfaction and Burnout among Flemish emergency physicians: a qualitative study.","authors":"Ine Van Bogaert,&nbsp;Catheline Depuydt,&nbsp;Said Hachimi-Idrissi","doi":"10.1080/17843286.2019.1629077","DOIUrl":"https://doi.org/10.1080/17843286.2019.1629077","url":null,"abstract":"<p><strong>Objectives: </strong>Emergency physicians have shown difficulties to combine their private and professional life. In addition to a very stressful environment, they have to deal with multiple sources of uncertainty. These factors may lead to psychological distress. The aim of this study is to determine the factors leading to dissatisfaction and burnout among Flemish emergency physicians (EPs). Which are the barriers hindering EPs to seek help and what are the potential solutions for this problem? <b>Methods:</b>This is a prospective, explorative qualitative study where seven Flemish EPs were interviewed. These were in-depth semi-structured interviews. The information from the interviews was analyzed using NVivo 12. <b>Results:</b>The common contributors were the working schedule, the increasing number of patients, the mental and physical impact of the job and the relatively low income. The most important barrier to seek help is the existence of an unforgiving medical culture. The solutions provided by the EPs are less patients and a better financing. <b>Conclusion:</b>Dissatisfaction and burnout are common among the EP profession. There is a need for awareness and a change in the unforgiving medical culture to a 'no shame no blame culture'. Improvement of EPs' work schedule and income to the level of other medical specialties are other important needs. Finally, reducing the number of patient contact at the emergency department, by highlighting the difference between medical urgency rather than personal convenience.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"75 5","pages":"329-333"},"PeriodicalIF":1.6,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17843286.2019.1629077","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37319948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Coombs-positive refractory acquired thrombotic thrombocytopenic purpura in a patient with chronic myelomonocytic leukemia successfully treated with rituximab. 康姆斯阳性难治性获得性血栓性血小板减少性紫癜在慢性髓单细胞白血病患者成功治疗利妥昔单抗。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2020-10-01 Epub Date: 2019-04-22 DOI: 10.1080/17843286.2019.1608395
Ivan Krecak, Marijana Grgic Medic, Velka Gveric-Krecak, Pavle Roncevic, Sandra Bašić Kinda, Jaksa Babel, Radovan Radonic
{"title":"Coombs-positive refractory acquired thrombotic thrombocytopenic purpura in a patient with chronic myelomonocytic leukemia successfully treated with rituximab.","authors":"Ivan Krecak,&nbsp;Marijana Grgic Medic,&nbsp;Velka Gveric-Krecak,&nbsp;Pavle Roncevic,&nbsp;Sandra Bašić Kinda,&nbsp;Jaksa Babel,&nbsp;Radovan Radonic","doi":"10.1080/17843286.2019.1608395","DOIUrl":"https://doi.org/10.1080/17843286.2019.1608395","url":null,"abstract":"<p><strong>Objectives: </strong>Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare autoimmune disorder characterized by auto-antibodies to Willebrand factor (vWF) cleaving enzyme (ADAMTS13), resulting in unusually large vWF multimers that lead to platelet aggregation, microthrombi formation and microangiopathic hemolytic anemia. Hemolysis in aTTP is mechanical; thus, direct antiglobulin test (Coombs test) is usually negative. Multiple autoimmune conditions and various auto-antibodies have been described in the context of chronic myelomonocytic leukemia (CMML). In this paper, we describe the first case of CMML with auto-antibodies to ADAMTS13, presenting initially as plasmapheresis-refractory Coombs-positive aTTP. <b>Results:</b> Although our patient was not treated for CMML, a complete remission of aTTP was eventually achieved with rituximab. Conclusion; We propose that aTTP should be in the differential diagnosis of CMML patients with thrombocytopenia and anemia (Coombs positive or not) who develop signs of thrombotic microangiopathy. Further studies are much needed to decipher the immune-mediated processes in CMML.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"75 5","pages":"357-361"},"PeriodicalIF":1.6,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17843286.2019.1608395","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37173030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The 2019 Flemish consensus on screening for overt diabetes in early pregnancy and screening for gestational diabetes mellitus. 2019年关于妊娠早期明显糖尿病筛查和妊娠期糖尿病筛查的佛兰德共识
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2020-10-01 Epub Date: 2019-07-01 DOI: 10.1080/17843286.2019.1637389
Katrien Benhalima, Caro Minschart, Paul Van Crombrugge, Peggy Calewaert, Johan Verhaeghe, Siska Vandamme, Katrien Theetaert, Roland Devlieger, Leen Pierssens, Hannah Ryckeghem, Els Dufraimont, Chris Vercammen, Ann Debie, Christophe De Block, Griet Vandenberghe, Sylva Van Imschoot, Sabine Verstraete, Luk Buyse, Johan Wens, Joke Muyldermans, Anissa Meskal, Sandy De Spiegeleer, Chantal Mathieu
{"title":"The 2019 Flemish consensus on screening for overt diabetes in early pregnancy and screening for gestational diabetes mellitus.","authors":"Katrien Benhalima,&nbsp;Caro Minschart,&nbsp;Paul Van Crombrugge,&nbsp;Peggy Calewaert,&nbsp;Johan Verhaeghe,&nbsp;Siska Vandamme,&nbsp;Katrien Theetaert,&nbsp;Roland Devlieger,&nbsp;Leen Pierssens,&nbsp;Hannah Ryckeghem,&nbsp;Els Dufraimont,&nbsp;Chris Vercammen,&nbsp;Ann Debie,&nbsp;Christophe De Block,&nbsp;Griet Vandenberghe,&nbsp;Sylva Van Imschoot,&nbsp;Sabine Verstraete,&nbsp;Luk Buyse,&nbsp;Johan Wens,&nbsp;Joke Muyldermans,&nbsp;Anissa Meskal,&nbsp;Sandy De Spiegeleer,&nbsp;Chantal Mathieu","doi":"10.1080/17843286.2019.1637389","DOIUrl":"https://doi.org/10.1080/17843286.2019.1637389","url":null,"abstract":"<p><p>Screening for gestational diabetes mellitus (GDM) is important to improve pregnancy outcomes and to prevent type 2 diabetes after pregnancy. The 'International Association of Diabetes and Pregnancy Study Groups' (IADPSG) recommends a universal one-step approach with the 75 g oral glucose tolerance test (OGTT) for screening of GDM. The IADPSG recommendation remains controversial due to the important increase in GDM prevalence and increased workload. After review of the latest evidence and based on data from the 'Belgian Diabetes in Pregnancy' study, members of the Diabetes Liga, the Flemish associations of general physicians (Domus Medica), obstetricians (VVOG), midwives (VVOB), diabetes nurse educators (BVVDV) and clinical chemists (RBSLM) have reached a new consensus on screening for GDM in Flanders. This new consensus recommends universal screening for overt diabetes when planning pregnancy or at the latest at first prenatal contact, preferably by measuring the fasting plasma glucose by using the same diagnostic criteria as in the non-pregnant state. In women with impaired fasting glycaemia, but also in normoglycemic obese women and women with a previous history of GDM, lifestyle counselling is advised with screening for GDM with a 75 g OGTT at 24 weeks. In all other women, we recommend a two-step screening strategy with a 50 g glucose challenge test (GCT) at 24 weeks followed by a 75 g OGTT when the glucose level 1 hour after the GCT ≥130 mg/dl. Diagnosis of GDM is made using the IADPSG criteria for GDM. Postpartum screening for subsequent glucose abnormalities should be advocated and organized for every woman with GDM.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"75 5","pages":"340-347"},"PeriodicalIF":1.6,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17843286.2019.1637389","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37382410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
The OptiLUTS trial: improving care for therapy-resistant symptoms of the pelvis in Belgium. OptiLUTS试验:改善比利时骨盆治疗抵抗症状的护理
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2020-10-01 Epub Date: 2019-06-18 DOI: 10.1080/17843286.2019.1630109
Lynn Ghijselings, Dirk Van De Putte, François Hervé, An-Sofie Goessaert, Dimitri Beeckman, Piet Pattyn, Karel Everaert
{"title":"The OptiLUTS trial: improving care for therapy-resistant symptoms of the pelvis in Belgium.","authors":"Lynn Ghijselings,&nbsp;Dirk Van De Putte,&nbsp;François Hervé,&nbsp;An-Sofie Goessaert,&nbsp;Dimitri Beeckman,&nbsp;Piet Pattyn,&nbsp;Karel Everaert","doi":"10.1080/17843286.2019.1630109","DOIUrl":"https://doi.org/10.1080/17843286.2019.1630109","url":null,"abstract":"<p><strong>Introduction/background: </strong>The management of therapy-resistant lower urinary tract symptoms (LUTS) and symptoms resulting from pelvic organ dysfunctions are subject to a high variability in the Belgian health-care centres. Practical guidelines and standardized patient clinical care pathways are often lacking and unadapted to the Belgian healthcare system.</p><p><strong>Objectives: </strong>The OptiLUTS trial aims to improve the multidisciplinary care of therapy-resistant symptoms of the pelvis in the Belgian healthcare setting. Project A aims for the improvement of knowledge of 2nd line treatments for LUTS among general practitioners. In project B a treatment algorithm for the overactive bladder syndrome and non-obstructive urinary retention will be developed specifically for Belgium. In Project C a patient customized sacral neuromodulation (SNM) care pathway will be set up.</p><p><strong>Methods: </strong>Part A: Explorative study among general practitioners by distribution of a  questionnaire. Part B: Review of existing guidelines and use of the Delphi method to obtain expert consensus. Part C: A single center comparative study to compare outcomes before and after implementation of the SNM care pathway. Patients scheduled for the first stage of Interstim therapy™ will be included (N=100). Primary endpoints are the sensitivity and specificity of a new pelvic symptom assessment tool, the conversion to implant and explantation rates.</p><p><strong>Conclusion: </strong>There is a margin for improvement in the care process of patients with therapy-resistant symptoms of the pelvis in the Belgium healthcare system. In the OptiLUTs trial adapted guidelines and a clinical care pathway will be developed to standardize and increase the efficiency of care.</p><p><strong>Trial registration: </strong>Approval for the trial by the Ethics Committee of the Ghent University hospital: EC/2018/0244.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"75 5","pages":"334-339"},"PeriodicalIF":1.6,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17843286.2019.1630109","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37338049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Uveitis as a window to diagnosis of sarcoidosis - case report and review of the literature. 葡萄膜炎作为结节病诊断的窗口——病例报告及文献复习。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2020-08-01 Epub Date: 2019-05-05 DOI: 10.1080/17843286.2019.1613309
Sebastiaan Dhont, Mathias Leys, Edward De Sutter, Herwig Alaerts, Wouter Van Moerkercke
{"title":"Uveitis as a window to diagnosis of sarcoidosis - case report and review of the literature.","authors":"Sebastiaan Dhont,&nbsp;Mathias Leys,&nbsp;Edward De Sutter,&nbsp;Herwig Alaerts,&nbsp;Wouter Van Moerkercke","doi":"10.1080/17843286.2019.1613309","DOIUrl":"https://doi.org/10.1080/17843286.2019.1613309","url":null,"abstract":"<p><p>Sarcoidosis is a multisystem disease of unclear etiology with a variable clinical profile characterized by the presence of non-caseating granuloma in involved organs. The diagnosis is often challenging and based on clinical, radiological and anatomopathological data. Sarcoidosis can be benign and self-limiting, but some cases may follow a chronic, progressive course and result in severe morbidity. The disease has a predilection for the lungs and thoracic lymph nodes but can involve nearly any part of the body, possible more commonly in areas with contact to the external environment, such as the eyes and the skin. This paper is based on a case in which a recurrent uveitis led to the diagnosis of an underlying sarcoidosis.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"75 4","pages":"245-249"},"PeriodicalIF":1.6,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17843286.2019.1613309","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37211774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hyperferritinemia, vasculitis and Mycoplasma pneumoniae. 高铁蛋白血症,血管炎和肺炎支原体。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2020-08-01 Epub Date: 2019-03-28 DOI: 10.1080/17843286.2019.1599549
Dimitri Poddighe
{"title":"Hyperferritinemia, vasculitis and <i>Mycoplasma pneumoniae</i>.","authors":"Dimitri Poddighe","doi":"10.1080/17843286.2019.1599549","DOIUrl":"https://doi.org/10.1080/17843286.2019.1599549","url":null,"abstract":"Dear Sir, I read with great interest the case report by Matthys I et al., describing a young adult patient with acute, sudden and severe clinical manifestations that the authors were able to correl...","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"75 4","pages":"311"},"PeriodicalIF":1.6,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17843286.2019.1599549","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37100531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperferritinemia associated with systemic manifestations of Mycoplasma pneumoniae infection. 高铁蛋白血症与肺炎支原体感染的全身表现有关。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2020-08-01 Epub Date: 2019-03-28 DOI: 10.1080/17843286.2019.1599569
Daniel Borsboom, Imke Matthys, Christophe Van Steenkiste
{"title":"Hyperferritinemia associated with systemic manifestations of Mycoplasma pneumoniae infection.","authors":"Daniel Borsboom,&nbsp;Imke Matthys,&nbsp;Christophe Van Steenkiste","doi":"10.1080/17843286.2019.1599569","DOIUrl":"https://doi.org/10.1080/17843286.2019.1599569","url":null,"abstract":"Dear Editor, We would like to comment on additional concerns that may rise about our manuscript ‘A plethora of manifestations following a Mycoplasma pneumoniae infection: a case report’[1]: 1. Rega...","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"75 4","pages":"312"},"PeriodicalIF":1.6,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17843286.2019.1599569","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37099320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of hemodialysis-related portosystemic encephalopathy and review of the literature. 血液透析相关门系统脑病1例及文献复习。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2020-08-01 Epub Date: 2019-03-28 DOI: 10.1080/17843286.2019.1595836
Barbara Geerinckx, Rachel Hellemans, Amaryllis H Van Craenenbroeck, Sven Francque, Liesbeth De Waele, Jeroen Kerstens, Pieter-Jan Van Gaal, Bart Bracke, Peter Michielsen, Thomas Vanwolleghem
{"title":"A rare case of hemodialysis-related portosystemic encephalopathy and review of the literature.","authors":"Barbara Geerinckx,&nbsp;Rachel Hellemans,&nbsp;Amaryllis H Van Craenenbroeck,&nbsp;Sven Francque,&nbsp;Liesbeth De Waele,&nbsp;Jeroen Kerstens,&nbsp;Pieter-Jan Van Gaal,&nbsp;Bart Bracke,&nbsp;Peter Michielsen,&nbsp;Thomas Vanwolleghem","doi":"10.1080/17843286.2019.1595836","DOIUrl":"https://doi.org/10.1080/17843286.2019.1595836","url":null,"abstract":"<p><p>Hemodialysis-related portosystemic encephalopathy (HRPSE) is a clinical phenomenon where portosystemic encephalopathy (PSE) develops without liver dysfunction, usually caused by changes in the portosystemic blood flow related to hemodialysis. We describe the case of a 22-year old patient with a transjugular intrahepatic portosystemic shunt (TIPS) who developed HRPSE several months after initiation of hemodialysis. Despite initial therapy with laxatives and neomycin symptoms recurred. It was only after relocation of the hemodialysis catheter from the superior caval vein to the femoral vein that symptoms completely resolved.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"75 4","pages":"296-300"},"PeriodicalIF":1.6,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17843286.2019.1595836","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37098188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信